Druggable Targets of Squamous Cell Lung Cancer

Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Cheol Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884109/
https://www.ncbi.nlm.nih.gov/pubmed/24416052
http://dx.doi.org/10.4046/trd.2013.75.6.231
_version_ 1782298515470286848
author Kim, Cheol Hyeon
author_facet Kim, Cheol Hyeon
author_sort Kim, Cheol Hyeon
collection PubMed
description Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.
format Online
Article
Text
id pubmed-3884109
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format MEDLINE/PubMed
spelling pubmed-38841092014-01-10 Druggable Targets of Squamous Cell Lung Cancer Kim, Cheol Hyeon Tuberc Respir Dis (Seoul) Review Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC. The Korean Academy of Tuberculosis and Respiratory Diseases 2013-12 2013-12-24 /pmc/articles/PMC3884109/ /pubmed/24416052 http://dx.doi.org/10.4046/trd.2013.75.6.231 Text en Copyright©2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
spellingShingle Review
Kim, Cheol Hyeon
Druggable Targets of Squamous Cell Lung Cancer
title Druggable Targets of Squamous Cell Lung Cancer
title_full Druggable Targets of Squamous Cell Lung Cancer
title_fullStr Druggable Targets of Squamous Cell Lung Cancer
title_full_unstemmed Druggable Targets of Squamous Cell Lung Cancer
title_short Druggable Targets of Squamous Cell Lung Cancer
title_sort druggable targets of squamous cell lung cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884109/
https://www.ncbi.nlm.nih.gov/pubmed/24416052
http://dx.doi.org/10.4046/trd.2013.75.6.231
work_keys_str_mv AT kimcheolhyeon druggabletargetsofsquamouscelllungcancer

Ejemplares similares